MIDDLEKAUFF W BRADFORD 4
4 · Immunovant, Inc. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
MIDDLEKAUFF W BRADFORD
General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-12-18+211,277→ 211,277 totalExercise: $7.86Exp: 2029-05-19→ Common Stock (211,277 underlying) - Award
Stock Option (right to buy)
2019-12-18+489→ 489 totalExercise: $7.86Exp: 2029-06-19→ Common Stock (489 underlying)
Footnotes (3)
- [F1]25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 12 equal quarterly installments thereafter.
- [F2]In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation ("HSAC") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd. (the "Business Combination Transaction"), the option to purchase 432,000 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC).
- [F3]In connection with the Business Combination Transaction, the option to purchase 1,000 shares of Immunovant Sciences Ltd. at exercise price of $3.84 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer.